Table 1.
HbA1c, FBG, FINS, and HOMA-IR and its comparison pre- and post-treatment
| Characteristics | n | Pretreatment | Posttreatment | P |
|---|---|---|---|---|
| BMI (kg/m2, mean±SD) | 40 | 29.80 ± 3.50 | 29.72 ± 3.55 | 0.191 |
| HbA1c (%, mean (range)) | 40 | 8.70 (7.40, 10.40) | 6.95 (6.38, 7.52) | <0.001 |
| FBG (mmol/L, mean±SD) | 40 | 9.35 ± 2.89 | 6.68 ± 1.19 | <0.001 |
| AHI, mean±SD | 40 | 30.66 ± 2.79 | 3.95 ± 0.35 | <0.001 |
| SBP (mmHg, mean±SD) | 40 | 129.53 ± 3.75 | 129.19 ± 3.77 | 0.83 |
| DBP (mmHg, mean±SD) | 40 | 86.51 ± 7.44 | 86.16 ± 7.78 | 0.83 |
| TC (mmol/L) | 40 | 6.07 ± 2.31 | 4.82 ± 1.09 | 0.219 |
| TG (mmol/L) | 40 | 2.64 ± 2.03 | 2.26 ± 1.43 | 0.307 |
| LDL-C (mmol/L) | 40 | 3.28 ± 1.10 | 2.64 ± 0.68 | 0.001 |
| FINS (µU/ml) | 40 | 8.06 (5.19, 13.70) | 8.30 (5.09, 11.30) | 0.442 |
| HOMA-IR | 40 | 3.57 (1.95, 5.08) | 2.48 (1.38, 3.90) | 0.013 |
BMI: Body mass index; HbA1c: Glycated hemoglobin; FBG: Fasten blood glucose; HOMA-IR: Homeostasis model assessment insulin resistance; AHI: Apneahypopnea index; SBP: Systolic blood pressure; DBP: Diastolic blood pressure; TC: Total cholesterol; TG: Triglyceride; FINS: Fasting insulin; LDL-C: Low density lipoproteincholesterol.